80 participants
Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-06-27
- Start Date:
- 2020-05-13
- Completion:
- 2022-12-30
Conditions
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Solid Tumor
Interventions
- DRUG
No Results Yet